SEARCH
'Historic moment' in race to beat Alzheimer's: Experimental brain plaque-busting drug 'signifi - 1br
1BN
2022-09-28
Views
4
Description
Share / Embed
Download This Video
Report
A large trial has shown an experimental Alzheimer's drug developed by Eisai Co Ltd and Biogen Inc to have significantly slowed decline of patients in the early stages of the disease.
VIEW MORE : https://bit.ly/1breakingnews
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x8e1myg" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
00:40
Biogen And Eisai To Move Forward With Alzheimer's Research
00:23
New Alzheimer's Drug From Biogen and Eisai Is Just the Beginning - 1breakingnews.com
01:00
El nuevo fármaco de Biogen y Eisai frena el deterioro cognitivo producido por alzhéimer
02:00
Biogen to ship Alzheimer's drug in two weeks
00:33
104952-mainHouse investigation faults FDA, Biogen for Alzheimer's drug approval - 1breakingnews.com
01:54
Biogen stock increases as Alzheimer's drug shows promise in early results of study - 1breakingnews.c
02:14
Biogen shares soar on Alzheimer's drug developments - 1breakingnews.com
03:10
Biogen Stock Rockets To Record High On Alzheimer's Drug Approval; 5
02:00
Biogen to ship Alzheimer's drug in two weeks
02:17
Biogen Plunges After FDA Says No to Alzheimer's Treatment
04:40
Eli Lilly's Alzheimer's moment has arrived after Biogen plows through the
03:30
FDA approves controversial Biogen Alzheimer's drug _ DW News
